Search
forLearn
5 / 801 resultslearn AHAs
learn APISCALP™
learn amla
learn acetyl cysteine
Research
5 / 499 results
research AAPS and PSRC 2016 Abstract Supplement
The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.
research Oral delivery of marine shellfish supramolecule peptides for skin wound healing
Eating peptides from certain shellfish may help wounds heal faster by reducing inflammation.
research Off-Label Treatment of Alopecia Areata—Retrospective Study
Off-label treatments are heavily used for alopecia areata due to limited approved options.
research Forehead-supporting chair system for follicular unit extraction hair transplantation
A forehead-supporting chair improves comfort and results in hair transplant surgery.
research Single-Layer vs. Double-Layer Donor Scalp Wound Closure in Strip Harvest.
Double-layer scalp wound closure is better than single-layer closure after strip hair transplant surgery.
Community Join
5 / 1000+ resultscommunity 31/M Indian. 6 month progress photos
A 31-year-old Indian man shared his 6-month hair loss progress using oral finasteride and topical minoxidil, showing noticeable improvement. Replies were positive, noting thicker hair and a better hairline.
community 6 months on biotin + minoxidil
A user shared a 6-month progress picture showing improvement in hair loss using biotin and minoxidil. They also mentioned dealing with stress, diet issues, and seborrheic dermatitis.
community Has anyone done research on Absci's AI‑driven antibody platform? Seeking your thoughts!
A user is interested in Absci's AI-driven antibody platform, ABS-201, for treating androgenetic alopecia, which shows promising preclinical results and potential for hair regrowth and pigmentation restoration. However, concerns are raised about the drug's development timeline and its advantages compared to existing treatments.
community Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 28th march
Pelage Pharmaceuticals' PP405 aims to treat hair loss by reactivating dormant hair follicle stem cells, showing promising results in early trials. The company plans to present their findings at the American Academy of Dermatology Annual Meeting in 2026.
community A Short Recap on PP405 and AAD 2026
PP405 is a promising experimental topical treatment for alopecia that reactivates dormant hair follicles by targeting cellular energy, with large-scale trials planned for 2026. While it shows potential, it cannot regenerate permanently destroyed follicles, making hair transplants the only guaranteed solution for advanced baldness currently.